Article Details

Chinese AI drug discovery startup XtaIPi secures $400m co-led by OrbiMed, HOPU

Retrieved on: 2021-08-12 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

Chinese AI drug discovery startup XtaIPi secures $400m co-led by OrbiMed, HOPU. View article details on hiswai:

Excerpt

A month ago, Hong Kong-based Insilico Medicine secured $255 million in a Series C round led by Warburg Pincus. This was followed by ...

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up